The topoisomerase II–Hsp90 complex: A new chemotherapeutic target?

Citations Over TimeTop 19% of 2005 papers

Abstract

The modulation of DNA topology by topoisomerase II plays a crucial role during chromosome condensation and segregation in mitosis and has thus become a highly attractive target for chemotherapeutic drugs. However, these drugs are highly toxic, and so new approaches are required. One such strategy is to target topoisomerase II-interacting proteins. Here we report the identification of potential topoisomerase II-associated proteins using immunoprecipitation, followed by 1-D and 2-D gel electrophoresis and MALDI-TOF mass spectrometry. A total of 23 proteins were identified and, of these, 17 were further validated as topoisomerase IIalpha-associated proteins by coimmunoprecipitation and Western blot. Six of the interacting proteins were cellular chaperones, including 3 members of the heat shock protein-90 (Hsp90) family, and so the effect of Hsp90 modulation on the antitumor activity of topoisomerase II drugs was tested using the sulforhodamine B assay, clonogenic assays and a xenograft model. The Hsp90 inhibitors geldanamycin, 17-AAG (17-allylamino-17-demethoxygeldanamycin) and radicicol significantly enhanced the activity of the topoisomerase II poisons etoposide and mitoxantrone in vitro and in vivo. Thus, our method of identifying topoisomerase II-interacting proteins appears to be effective, and at least 1 novel topoisomerase IIalpha-associated protein, Hsp90, may represent a valid drug target in the context of topoisomerase II-directed chemotherapy.

Related Papers

• → Heat Shock Protein 90 Modulates the Unfolded Protein Response by Stabilizing IRE1α(2002)236 cited
• → Molybdate Inhibits Hsp90, Induces Structural Changes in Its C-Terminal Domain, and Alters Its Interactions with Substrates(1999)75 cited
• → Geldanamycin and its derivatives as Hsp90 inhibitors(2012)88 cited
• → Molecular chaperone HSP90 as a novel target for cancer chemotherapy.(2003)13 cited
• → Design, Synthesis, and StructureActivity Relationships for Chimeric Inhibitors of Hsp90(2006)39 cited